Publication November 12, 2026

Insulin Lispro Featured in New Annual Review of Medicine Publication

A publication referencing insulin lispro appeared in the Annual Review of Medicine on November 12, 2026. The article is titled "Rapidly Evolving Insulin Landscape: Ultrashort Acting and Ultralong Acting." This entry marks the publication date as recorded in the source listing. No specific findings, data, or conclusions from the article have been provided alongside this listing. The publication is catalogued under the identifier 43019456. Insulin lispro remains an approved compound according to current regulatory status. Readers interested in the broader context of ultrashort acting and ultralong acting insulin developments may wish to review the full article directly through the journal. This brief reports only the existence and basic bibliographic details of the publication as supplied. No efficacy, safety, or outcome information is included here, as none was furnished in the event data. Those seeking more detail on the content or conclusions of the review should consult the original source. For general background on insulin lispro, readers can refer to the compound overview.

See the full insulin lispro overview

Source: https://pubmed.ncbi.nlm.nih.gov/43019456/